Investigative and Clinical Urology

The Korean Urological Association (대한비뇨의학회)
권호 표지
DOI QR코드

DOI QR Code

Predictors of PSA Screening Among Men Over 40 Years of Age Who Had Ever Heard about PSA

  • Received : 2010.04.21
  • Accepted : 2010.05.31
  • Published : 2010.06.22
⟨ Previous Next ⟩

Abstract

Purpose: The purpose of this study was to investigate social and behavioral factors associated with prostate-specific antigen (PSA) screening in men in California, United States, who were over 40 years of age and had ever heard about PSA screening. Materials and Methods: This survey was administered as a random-digit-dialing telephone survey to produce reliable estimates of medium-sized counties. It surveyed 42,000 households and interviewed 58,407 people randomly. It considered socioeconomic status and health behavior as affecting PSA screening. Access to health care was measured as having regular health care access. The main outcome measure was self-report of ever having undergone PSA screening at least once in the respondent's lifetime. Results: Of 8,864 respondents, 82.2% were White, 7.7% were Latin, 4.2% were African American, and 5.9% were Asian. The respondents' mean age was 60.13 years. Age was the significant factor for PSA screening. Respondents aged 50-59 years were 3.5 times as likely to have undergone PSA screening as were those aged 40-49 years (OR=3.49, p$\leq$0.001). Race was not statistically significant after considering other factors. People who had never married had statistically significantly lower screening than did people who were married (OR=0.71, p=0.001). Poverty levels were statistically significant in both the unadjusted and the adjusted analysis. People who had no regular health care access were much less likely to have undergone PSA screening than were people who had regular health care access (OR=0.22, p=0.001). Conclusions: The likelihood of PSA screening was positively associated with increased age, marital status (married), higher socioeconomic status (higher federal poverty level and higher educational attainment), and health care access. However, there was no statistically significant association of PSA screening with race, employment, exercise, smoking, or drinking status.

Keywords

References

  1. Klein EA, Platz EA, Thompson IM. Epidemiology, etiology, and prevention of prostate cancer. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders; 2007;2854-73.
  2. Sirovich BE, Schwartz LM, Woloshin S. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence? JAMA 2003;289:1414-20. https://doi.org/10.1001/jama.289.11.1414
  3. Smith RA, von Eschenbach AC, Wender R, Levin B, Byers T, Rothenberg D, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001-- testing for early lung cancer detection. CA Cancer J Clin 2001; 51:38-75. https://doi.org/10.3322/canjclin.51.1.38
  4. Smith DS, Bullock AD, Catalona WJ, Herschman JD. Racial differences in a prostate cancer screening study. J Urol 1996;156: 1366-9. https://doi.org/10.1016/S0022-5347(01)65588-5
  5. Liu L, Cozen W, Bernstein L, Ross RK, Deapen D. Changing relationship between socioeconomic status and prostate cancer incidence. J Natl Cancer Inst 2001;93:705-9. https://doi.org/10.1093/jnci/93.9.705
  6. Ross LE, Coates RJ, Breen N, Uhler RJ, Potosky AL, Blackman D. Prostate-specific antigen test use reported in the 2000 National Health Interview Survey. Prev Med 2004;38:732-44. https://doi.org/10.1016/j.ypmed.2004.01.005
  7. Jones BA, Liu WL, Araujo AB, Kasl SV, Silvera SN, Solar-Vila H, et al. Explaining the race difference in prostate cancer stage at diagnosis. Cancer Epidemiol Biomarkers Prev 2008;17:2825- 34. https://doi.org/10.1158/1055-9965.EPI-08-0203
  8. Resnick MJ, Canter DJ, Guzzo TJ, Bruker BM, Bergey M, Sonnad SS, et al. Does race affect postoperative outcomes in patients with low-risk prostate cancer who undergo radical prostatectomy? Urology 2009;73:620-3. https://doi.org/10.1016/j.urology.2008.09.035
  9. Stattin P, Holmberg E, Bratt O, Adolfsson J, Johansson JE, Hugosson J. Surveillance and deferred treatment for localized prostate cancer. Population based study in the National Prostate Cancer Register of Sweden. J Urol 2008;180:2423-9. https://doi.org/10.1016/j.juro.2008.08.044
  10. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control 2009;20:417-35. https://doi.org/10.1007/s10552-008-9256-0
  11. Pearlman DN, Rakowski W, Ehrich B, Clark MA. Breast cancer screening practices among black, Hispanic, and white women: reassessing differences. Am J Prev Med 1996;12:327-37.
  12. Phillips KA, Kerlikowske K, Baker LC, Chang SW, Brown ML. Factors associated with women's adherence to mammography screening guidelines. Health Serv Res 1998;33:29-53.
  13. Potosky AL, Breen N, Graubard BI, Parsons PE. The association between health care coverage and the use of cancer screening tests. Results from the 1992 National Health Interview Survey. Med Care 1998;36:257-70. https://doi.org/10.1097/00005650-199803000-00004
  14. Breen N, Wagener DK, Brown ML, Davis WW, Ballard-Barbash R. Progress in cancer screening over a decade: results of cancer screening from the 1987, 1992, and 1998 National Health Interview Surveys. J Natl Cancer Inst 2001;93:1704-13. https://doi.org/10.1093/jnci/93.22.1704

Cited by

  1. Does Bicycle Riding Impact the Development of Lower Urinary Tract Symptoms and Sexual Dysfunction in Men? vol.52, pp.5, 2010, https://doi.org/10.4111/kju.2011.52.5.350
  2. Changes over time in the effect of marital status on cancer survival vol.11, pp.1, 2010, https://doi.org/10.1186/1471-2458-11-804
  3. DNA Methylation of GSTP1 in Human Prostate Tissues: Pyrosequencing Analysis vol.53, pp.3, 2010, https://doi.org/10.4111/kju.2012.53.3.200
  4. The Establishment of K-CaP (the Multicenter Korean Prostate Cancer Database) vol.54, pp.4, 2010, https://doi.org/10.4111/kju.2013.54.4.229
  5. A prospective study of socioeconomic status, prostate cancer screening and incidence among men at high risk for prostate cancer vol.24, pp.2, 2013, https://doi.org/10.1007/s10552-012-0108-6
  6. Do the values of prostate specific antigen obtained from fresh and dried urine reflect the serum measurements? vol.5, pp.2, 2010, https://doi.org/10.4103/0974-7796.110006
  7. Health disparities in clinical practice patterns for prostate cancer screening by geographic regions in the United States: a multilevel modeling analysis vol.16, pp.2, 2010, https://doi.org/10.1038/pcan.2013.3
  8. The Influence of Family Ties on Men’s Prostate Cancer Screening, Biopsy, and Treatment Decisions vol.7, pp.6, 2010, https://doi.org/10.1177/1557988313480226
  9. Determination of common urine substances as an assay for improving prostate carcinoma diagnostics vol.31, pp.4, 2010, https://doi.org/10.3892/or.2014.3054
  10. Predictors of Participation in Prostate Cancer Screening among Older Men in Jordan vol.16, pp.13, 2010, https://doi.org/10.7314/apjcp.2015.16.13.5377
  11. A Nationwide Survey of Prostate Specific Antigen Based Screening and Counseling for Prostate Cancer vol.4, pp.3, 2010, https://doi.org/10.1016/j.urpr.2016.06.005
  12. Knowledge, Perceived Risk and Utilization of Prostate Cancer Screening Services among Men in Dar Es Salaam, Tanzania vol.2019, pp.None, 2019, https://doi.org/10.1155/2019/2463048
  13. Digital rectal examination and its associated factors in the early detection of prostate cancer: a cross-sectional population-based study vol.19, pp.1, 2010, https://doi.org/10.1186/s12889-019-7946-z
  14. Predictors of prostate‐specific antigen testing in men aged ≥55 years: A cross‐sectional study based on patient‐reported outcomes vol.27, pp.9, 2010, https://doi.org/10.1111/iju.14276